Cargando…

Electrocardiogram Characteristics and Prognostic Value in Light-Chain Amyloidosis: A Comparison With Cardiac Magnetic Resonance Imaging

Background: An electrocardiogram (ECG) is a simple and cheap non-invasive tool that shows various abnormalities and has prognostic value for patients with light-chain amyloidosis (AL). The present study aimed to explore the association between ECG characteristics and cardiac magnetic resonance (CMR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Xinli, Chen, Zhian, Wan, Ke, Song, Rizhen, Yang, Tingjie, Xu, Yuanwei, Zhang, Qing, Alexander, Kevin Michael, Han, Yuchi, Chen, Yucheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685267/ https://www.ncbi.nlm.nih.gov/pubmed/34938781 http://dx.doi.org/10.3389/fcvm.2021.751422

Ejemplares similares

Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis
por: Wan, Ke, et al.
Publicado: (2017)

Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis
por: Zhang, Yang, et al.
Publicado: (2021)

The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients
por: Yue, Xiuzheng, et al.
Publicado: (2022)

The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis
por: Miao, Fujia, et al.
Publicado: (2023)

Prognostic value of right atrial strain derived from cardiovascular magnetic resonance in non-ischemic dilated cardiomyopathy
por: Li, Yangjie, et al.
Publicado: (2022)

Cardiovascular toxicity from therapies for light chain amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2023)

Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

The Value of Cardiac Magnetic Resonance Imaging in Identification of Rare Diseases Mimicking Hypertrophic Cardiomyopathy
por: Fang, Tingting, et al.
Publicado: (2021)

Corrigendum: Prognostic implication of longitudinal changes of left ventricular global strain after chemotherapy in cardiac light chain amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

Diagnostic and Prognostic Values of Cardiopulmonary Exercise Testing in Cardiac Amyloidosis
por: Banydeen, Rishika, et al.
Publicado: (2022)

Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
por: Baker, Kelty R.
Publicado: (2022)

The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis
por: Lin, Lu, et al.
Publicado: (2018)

Myocardial Biopsy in a History of Light-Chain Amyloidosis Patient With Serial Cardiac Magnetic Resonance Imaging Not Suggestive of Cardiac Involvement
por: Mizutani, Hana, et al.
Publicado: (2019)

Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis
por: Venkatesh, Sudhakar K., et al.
Publicado: (2019)

High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis
por: Li, Muzheng, et al.
Publicado: (2021)

Grade 3 myocardial uptake in (99m)technetium-pyrophosphate scintigraphy in light chain cardiac amyloidosis
por: Okada, Atsushi, et al.
Publicado: (2021)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment
por: Martinez-Naharro, Ana, et al.
Publicado: (2022)

Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis
por: Ochs, Marco M., et al.
Publicado: (2017)

Clinical characteristics and prognostic value of renal immune complex deposition in patients with light chain amyloidosis
por: Yan, Jipeng, et al.
Publicado: (2022)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Prognostic value of fast semi-automated left atrial long-axis strain analysis in hypertrophic cardiomyopathy
por: Yang, Fuyao, et al.
Publicado: (2021)

A Risk Score to Diagnose Cardiac Involvement and Provide Prognosis Information in Patients at Risk of Cardiac Light-Chain Amyloidosis
por: Wu, Yan, et al.
Publicado: (2022)

Sick sinus syndrome associated with Erdheim-Chester disease was reversed by interferon-alpha treatment
por: Guo, Xinli, et al.
Publicado: (2022)

False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain: Case report
por: Zeng, Yu, et al.
Publicado: (2021)

Feature tracking cardiac magnetic resonance in systemic light chain amyloidosis
por: Kammerer, Rebekka, et al.
Publicado: (2013)

Cardiac magnetic resonance strain imaging in systemic light chain amyloidosis
por: Andre, Florian, et al.
Publicado: (2014)

Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis
por: Scheel, Paul J., et al.
Publicado: (2022)

Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis
por: Usuku, Hiroki, et al.
Publicado: (2023)

CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
por: Wang, Fangqing, et al.
Publicado: (2023)

Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis
por: Arenja, Nisha, et al.
Publicado: (2019)

Significant role of magnetic resonance imaging for the diagnosis and evaluation of cardiac amyloidosis in primary light chain amyloidosis
por: Sekiguchi, Yasunobu, et al.
Publicado: (2020)

Prognostic Value of Hepatic Native T1 and Extracellular Volume Fraction in Patients with Pulmonary Arterial Hypertension
por: Guo, Jiajun, et al.
Publicado: (2022)

Multiparametric mapping by cardiovascular magnetic resonance imaging in cardiac tumors
por: Yue, Pengfei, et al.
Publicado: (2023)

Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study
por: Liu, Xiao-hang, et al.
Publicado: (2022)

Multiorgan involvement by amyloid light chain amyloidosis
por: Li, Guoliang, et al.
Publicado: (2019)

High Serum Lactate Dehydrogenase adds Prognostic Value to Cardiac Biomarker Staging System for Light Chain Amyloidosis
por: He, Haiyan, et al.
Publicado: (2019)

Prognostic and diagnostic accuracy of intracoronary electrocardiogram recorded during percutaneous coronary intervention: a meta-analysis
por: Li, Weijie, et al.
Publicado: (2022)

Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1gl46d8qik2fui8lkm27g8863s